|
[Related PubMed/MEDLINE]
Total Number of Papers: 9
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: PsA |
| Long Form |
: psammaplin A |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2016 |
Morphokinetics of cloned mouse embryos treated with epigenetic drugs and blastocyst prediction. |
ESC, SCNT, Vit C |
| 2 |
2015 |
Determination and validation of psammaplin A and its derivatives in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic study. |
ESI, IS, MRM |
| 3 |
2015 |
Improved development of somatic cell cloned mouse embryos by vitamin C and latrunculin A. |
LatA, SCNT, Vit C |
| 4 |
2015 |
Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. |
DRAM |
| 5 |
2014 |
Psammaplin a improves development and quality of somatic cell nuclear transfer mouse embryos. |
HDACi, VPA |
| 6 |
2012 |
Pharmacokinetics and tissue distribution of psammaplin A, a novel anticancer agent, in mice. |
--- |
| 7 |
2008 |
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. |
HDAC |
| 8 |
2004 |
Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro. |
APN |
| 9 |
1999 |
Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells. |
EC50, MDR, P-gp, topo II, VER |
|
A Search Service for Abbreviation / Long Form
